Apothékary, the herbal tincture brand positioning its products as replacements for daily habits like caffeine and alcohol, has raised $16 million – $10 million in venture capital and $6 million in debt financing. Investors include Shiseido (through its venture arm LIFT), NextLevel Management, RSF Social Finance, and roughly 50 angel investors. Total funding to date is approximately $32 million.
Founded in 2020 by Shizu Okusa, a former Goldman Sachs trader, Apothékary sells supplements addressing energy, digestion, sleep, and stress. The brand is targeting $40 million in 2026 sales with 30-40% year-over-year growth according to the company, and has expanded into Ulta Beauty, Whole Foods, and The Vitamin Shoppe alongside existing distribution through Free People, Sprouts, and Amazon.
